Capital Analysts, LLC Abbott Laboratories Transaction History

Capital Analysts, LLC

  • $2.14 Billion
  • Q1 2024

A detailed history of Capital Analysts, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Analysts, LLC holds 79,462 shares of ABT stock, worth $8.27 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
79,462
Previous 78,516 1.2%
Holding current value
$8.27 Million
Previous $8.64 Million 4.5%
% of portfolio
0.42%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$109.52 - $120.96 $103,605 - $114,428
946 Added 1.2%
79,462 $9.03 Million
Q4 2023

Jan 30, 2024
BUY
$90.19 - $110.4 $182,634 - $223,560
2,025 Added 2.65%
78,516 $8.64 Million
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $612,251 - $734,599
6,409 Added 9.15%
76,491 $7.41 Million
Q2 2023

Aug 11, 2023
BUY
$100.78 - $112.29 $422,973 - $471,281
4,197 Added 6.37%
70,082 $7.64 Million
Q1 2023

May 05, 2023
BUY
$96.86 - $114.01 $331,164 - $389,800
3,419 Added 5.47%
65,885 $6.67 Million
Q4 2022

Feb 08, 2023
BUY
$95.06 - $111.52 $214,360 - $251,477
2,255 Added 3.75%
62,466 $6.86 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $396,425 - $458,986
4,097 Added 7.3%
60,211 $5.83 Million
Q2 2022

Aug 12, 2022
BUY
$102.07 - $123.37 $237,108 - $286,588
2,323 Added 4.32%
56,114 $6.1 Million
Q1 2022

May 12, 2022
BUY
$114.02 - $139.04 $298,276 - $363,728
2,616 Added 5.11%
53,791 $6.37 Million
Q4 2021

Feb 10, 2022
BUY
$115.53 - $141.46 $193,859 - $237,369
1,678 Added 3.39%
51,175 $7.2 Million
Q3 2021

Nov 04, 2021
BUY
$116.66 - $129.06 $109,077 - $120,671
935 Added 1.93%
49,497 $5.85 Million
Q2 2021

Nov 15, 2021
SELL
$105.79 - $124.53 $65,801 - $77,457
-622 Reduced 1.26%
48,562 $5.63 Million
Q2 2021

Aug 05, 2021
BUY
$105.79 - $124.53 $172,120 - $202,610
1,627 Added 3.42%
49,184 $5.7 Million
Q1 2021

May 17, 2021
SELL
$108.84 - $128.23 $61,059 - $71,937
-561 Reduced 1.17%
47,557 $5.7 Million
Q4 2020

Feb 16, 2021
BUY
$105.0 - $114.42 $85,050 - $92,680
810 Added 1.71%
48,118 $5.27 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $118,490 - $143,897
-1,293 Reduced 2.66%
47,308 $5.15 Million
Q2 2020

Aug 07, 2020
SELL
$76.57 - $98.0 $191,654 - $245,294
-2,503 Reduced 4.9%
48,601 $4.44 Million
Q1 2020

May 08, 2020
BUY
$62.82 - $91.86 $69,730 - $101,964
1,110 Added 2.22%
51,104 $4.03 Million
Q4 2019

Feb 12, 2020
BUY
$78.51 - $87.4 $44,593 - $49,643
568 Added 1.15%
49,994 $4.34 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $737,869 - $800,079
-9,016 Reduced 15.43%
49,426 $4.14 Million
Q2 2019

Aug 13, 2019
SELL
$72.88 - $85.0 $227,021 - $264,775
-3,115 Reduced 5.06%
58,442 $4.92 Million
Q1 2019

May 13, 2019
SELL
$66.22 - $80.06 $158,596 - $191,743
-2,395 Reduced 3.74%
61,557 $4.92 Million
Q4 2018

Feb 13, 2019
SELL
$65.56 - $74.27 $11,538 - $13,071
-176 Reduced 0.27%
63,952 $4.63 Million
Q3 2018

Nov 07, 2018
BUY
$60.81 - $73.36 $108,059 - $130,360
1,777 Added 2.85%
64,128 $0
Q2 2018

Aug 03, 2018
SELL
$57.57 - $63.54 $483,645 - $533,799
-8,401 Reduced 11.87%
62,351 $0
Q1 2018

May 14, 2018
BUY
$56.27 - $63.62 $74,501 - $84,232
1,324 Added 1.91%
70,752 $4.24 Million
Q4 2017

Feb 14, 2018
BUY
$53.68 - $57.47 $3.1 Million - $3.32 Million
57,790 Added 496.56%
69,428 $3.96 Million
Q4 2017

Feb 12, 2018
SELL
$53.68 - $57.47 $3 Million - $3.21 Million
-55,824 Reduced 82.75%
11,638 $453,000
Q3 2017

Nov 06, 2017
BUY
$48.06 - $53.64 $3.24 Million - $3.62 Million
67,462
67,462 $3.6 Million

Others Institutions Holding ABT

# of Institutions
3,130
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.71M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email